pd 169316 has been researched along with Anaphylactic Reaction in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chue, SC | 1 |
| Seow, CJ | 1 |
| Duan, W | 1 |
| Yeo, KS | 1 |
| Koh, AH | 1 |
| Wong, WS | 1 |
1 other study available for pd 169316 and Anaphylactic Reaction
| Article | Year |
|---|---|
Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro.
Topics: Anaphylaxis; Animals; Bronchi; Bronchoconstriction; Butadienes; Calcium-Calmodulin-Dependent Protein | 2004 |